By Matt Bernardini ( February 28, 2019, 10:10 PM GMT) -- Actavis illegally made monthly payments to Waymade to not enter the market for a generic hormone-replacement treatment and then charged the country's national health care provider excessive prices for the drug, the U.K.'s antitrust regulator said Thursday....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.